Paget-Schroetter Syndrome Associated with FV:Q506 and Prothrombin 20210A

Abstract

Effort thrombosis of the axillary-subclavian vein (Paget-Schroetter syndrome) develops usually secondary to heavy arm exertion. An underlying chronic venous compressive anomaly at the thoracic outlet or intimal damage of the axillary vein following forceful hyperabduction, external rotation of the shoulder joint has been proposed to explain the pathophysiology of this thrombosis. This condition is usually not attributed to an under lying hypercoagulability such as deficiency of natural coagulation inhibitors. Here, the authors present a case with thrombosis of the axillary-subclavian vein following an effort, with factor V Leiden and prothrombin 20210A mutations. Both factor V Leiden and the genetic variant in the prothrombin gene have been shown to confer an increased risk for venous thrombosis. Although rare, effort thrombosis may develop in a patient with hereditary thrombophilia, so laboratory evaluation should include the common causes of thrombosis.

Get full access to this article

View all access options for this article.

References

Aziz S. , Straehley CJ , Whelan TJ : Effort related axillosubclavian vein thrombosis. Am J Surg 152:57-61, 1986.

Adams JT , Deweese JA : Effort thrombosis of the axillary and subclavian veins. J Trauma 11:923-930, 1971.

Dahlbäck B. , Carlsson M. , Svensson PJ : Familial thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C Proc Natl Acad Sci USA 90:1004-1008, 1993.

Bertina RM , Koeleman Bpc , Koster T. , et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67, 1994.

Voorberg J. , Roelse J. , Koopman R. , et al: Association of idiopathic venous thromboembolism with a single point mutation at Arg506 of factor V. Lancet 343:1535-1536, 1994.

Svensson PJ , Dahlbäck B. : Resistance to activated protein C as a basis of venous thromboembolism . N Engl J Med 330:517-522, 1994.

Port SR , Rosendaal FR , Reitsma PH , et al: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.

Daskalakis E. , Bouhoutsos J. : Subclavian and axillary vein compression of musculoskeletal origin. Br J Surg 67:573-576, 1980.

Lindblad B. , Tengborn L. , Bergqvist D. : Deep vein thrombosis of the axillary-subclavian veins: Epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg 2:161-165, 1988.

10.

Ochsner A. , DeBakey M. , DeCamp PT , et al: Thromboembolism : Analysis of cases at Charity Hospital in New Orleans over a 12-year period. Arch Surg 134:405, 1951.

11.

Gürgey A. , Mesci L. : The prevalence of factor V Leiden mutation in Turkish population. Turk J Pediatr 39:310-315, 1997.

12.

Gürgey A. , Mesci L. , Renda Y. , et al: Factor V Leiden mutation in children with thrombosis. Am J Hematol 53:37-39, 1996.

13.

Rosendaal FR , Koster T. , Vandenbrouke JP , et al: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504-1508, 1995 .

14.

Ridker PM , Hennekens CH , Lindpaintner K. , et al: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thromboembolism in apparently healthy men. N Engl J Med 332:912-917, 1995.

15.

Hellgren M. , Svensson PJ , Dahlbäck B. : Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives . Am J Obstet Gynecol 173:210-213, 1995.

16.

Cumming AM , Keeney S. , Salden A. , et al: The prothrombin gene G20210A variant: Prevalence in a U.K. anticoagulant clinic population. Br J Haematol 98:353-355, 1997.

17.

Ehrenforth S. , Ludwing G. , Klinke S. , et al: The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia. Blood 91:2209-2210, 1998.

18.

Zöller B. , Svensson PJ , Dahlbäck B. , et al. The 20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families. Blood 91:2210-2211, 1998.

19.

Makris M. , Preston FE , Beauchamp NJ , et al: Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 78:1426-1429,1997.